共 50 条
- [43] Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes DIABETES CARE, 2022, 45 (05) : 1170 - 1176
- [48] Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018, 11 : 289 - 301